Evias Pharmaceutical R&D Ltd.

Evolution VIA Science

Address: Gazi Teknopark 10/50A/21 Gölbaşı 06830, Ankara, Türkiye

Phone: +90 312 920 0270 Fax: +90 312 920 0271

Email: info@evias.com.tr

Dr. Abdurrahman Olğaç

Dr. Abdurrahman Olğaç

CEO & Founder

Dr. Abdurrahman Olğaç bridges his deep academic background in computational pharmaceutical chemistry with the R&D ecosystem. Specializing in AI-driven drug discovery and molecular modeling, he shapes the architecture of Evias Cloud and spearheads innovative R&D projects within Evias.

Prof. Dr. Erden Banoğlu

Prof. Dr. Erden Banoğlu

Scientific Director

Prof. Dr. Erden Banoğlu is a pioneering figure in medicinal chemistry and pharmaceutical R&D in Türkiye. He steers Evias’ scientific strategy and, as the visionary who coined the company’s name and shaped its core philosophy, serves as the company’s primary driving force and strategic cornerstone. Since its inception, he has played a pivotal role in Evias’ day-to-day operational leadership and management.

Projects

Leukotriene Biosynthesis

Exploring the regulation of leukotriene biosynthesis during inflammatory responses, focusing on pathway modulation and therapeutic insights.

Prostaglandin Biosynthesis

Optimizing biocatalytic strategies for the synthesis of prostaglandin intermediates with improved selectivity, efficiency, and scalability.

Evias Cloud

A secure, cloud‑native R&D platform enabling experiment capture, molecular modeling, data analysis, and real‑time scientific collaboration.

Latest Updates

Contact Us

Easily reach us by filling out the form below.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Profile

We use cookies and similar technologies to ensure the proper functioning of this website, improve user experience, analyze traffic, and support our services.

By clicking “Accept”, you consent to the use of cookies in accordance with our Privacy & Cookie Policy.